Document Detail


Factors associated with anemia among incident pre-dialysis patients managed within a French care network.
MedLine Citation:
PMID:  17338427     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: Despite guidelines concerning the management of renal anemia, the international literature reports that a large proportion of pre-dialysis patients have hemoglobin values lower than the recommended level. The present study analyzed the evolution of pre-dialysis Hb levels and erythropoietin use over a 4-year period and investigated factors associated with anemia. METHODS: A total of 1315 patients initiating dialysis in Lorraine, France, were enrolled since 2001-2004. For each year, anemia, defined by Hb <11 g/dl, and erythropoietin use were investigated in three groups: all patients, patients whose dialysis was planned and patients whose dialysis was unplanned. RESULTS: At initiation of dialysis, all groups showed increases over time in mean hemoglobin levels, proportion of patients without anemia and with erythropoietin therapy. Among patients whose first dialysis was planned in 2004, 43.8% had anemia and 67.9% had received erythropoietin, compared with 75.4% and 29.4%, respectively, when dialysis was unplanned. Patients receiving unplanned dialysis were more likely to have anemia (odds ratio (OR) = 2.6), as were those with a serum albumin level < 3.5 g/dl (OR = 2.1), body mass index < 30 kg/m2 (OR = 1.9) (all p < 0.001) or glomerular filtration rate < 10 ml/min/1.73 m2 (OR = 1.4, p = 0.04). The year of dialysis initiation was also associated with anemia (p = 0.024). CONCLUSION: The proportion ofpatients starting dialysis with anemia might be reduced by earlier nephrology referral leading to erythropoietin administration, planned first dialysis while residual renal function remains, and greater attention to nutritional status.
Authors:
N Thilly; S Boini; C Loos-Ayav; M Kessler; S Briançon; L Frimat
Related Documents :
11032357 - Early epoetin treatment in patients with renal insufficiency.
7329997 - Assessing the adequacy of dialysis.
7753457 - Plasma kinetics of 125i-labelled amyloid p component in beta 2m amyloidosis: a possible...
7218657 - Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness.
9793867 - The natural history and pathophysiology of treatment resistant schizophrenia.
23222167 - The association between the 4g/5g polymorphism in the promoter of the plasminogen activ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nephrology     Volume:  67     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-03-06     Completed Date:  2007-04-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  81-8     Citation Subset:  IM    
Affiliation:
Department of Clinical Epidemiology and Evaluation, CEC-CIE6 Inserm (EA 4003), Nancy, France. n.thilly@chu-nancy.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anemia / blood*
Erythropoietin, Recombinant / therapeutic use
Female
France
Humans
Kidney Failure, Chronic / blood*
Male
Middle Aged
Renal Replacement Therapy*
Chemical
Reg. No./Substance:
0/Erythropoietin, Recombinant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association between the clara cell secretory protein (CC16) G38A polymorphism and the progression of...
Next Document:  Evaluation of the role of severe hyperparathyroidism on coronary artery calcification in dialysis pa...